Explore the words cloud of the Ocean Medicines project. It provides you a very rough idea of what is the project "Ocean Medicines" about.
The following table provides information about the project.
CONSIGLIO NAZIONALE DELLE RICERCHE
|Coordinator Country||Italy [IT]|
|Total cost||360˙000 €|
|EC max contribution||360˙000 € (100%)|
1. H2020-EU.1.3.3. (Stimulating innovation by means of cross-fertilisation of knowledge)
|Duration (year-month-day)||from 2015-12-01 to 2019-11-30|
Take a look of project's partnership.
|1||CONSIGLIO NAZIONALE DELLE RICERCHE||IT (ROMA)||coordinator||45˙000.00|
|2||EPI-C SRL||IT (NAPOLI)||participant||54˙000.00|
|3||SEA4US BIOTECNOLOGIA E RECURSOS MARINHOS LDA||PT (SAGRES)||participant||54˙000.00|
|4||UNIVERSITETET I TROMSOE - NORGES ARKTISKE UNIVERSITET||NO (TROMSO)||participant||54˙000.00|
|5||FUNDACION CENTRO DE EXCELENCIA EN INVESTIGACION DE MEDICAMENTOS INNOVADORES EN ANDALUCIA||ES (ARMILLA GRANADA)||participant||49˙500.00|
|6||STAZIONE ZOOLOGICA ANTON DOHRN||IT (NAPOLI)||participant||45˙000.00|
|7||THE UNIVERSITY COURT OF THE UNIVERSITY OF ABERDEEN||UK (ABERDEEN)||participant||36˙000.00|
|8||BIOSEARCH SRL||IT (NAPOLI)||participant||22˙500.00|
|10||SEALIFE PHARMA GMBH||AT (TULLN)||participant||0.00|
|11||UNIVERSITY OF THE WESTERN CAPE||ZA (CAPE TOWN)||partner||0.00|
Marine organisms have the capacity to produce a variety of biologically potent natural products. Such novel molecules have new mechanisms of action and therefore could be used to treat human diseases and enhance the quality of life, especially in the ageing segment of the population. However, although there is growing interest in marine natural products (MNP) as potential therapeutic agents for human age-related diseases, few MNPs have reached clinical trials and the market. To fully exploit these promising biological resources, new strategies in the pipeline as well as a new cohort of cross-disciplinary trained scientists are needed to overcome existing bottlenecks and ensure the production of high value biomolecules. Ocean Medicines is a network of academic, research centres and SMEs across Europe, with proven experience in higher education, training and endowed with state-of-the art scientific and technical expertise and infrastructures. Our aim is to establish a network of collaboration and knowledge-exchange between industrial and academic partners to further develop lead compounds from marine microorganisms having anticancer or anti-infective effects that have already been identified by the consortium. To achieve this a secondment programme will be set up to prepare a new generation of marine biodiscovery scientists that will be trained on how to isolate compounds from bioactive bacteria/microalgae and take these through to semi-industrial scale-up for further development and toxicity testing at the pre-clinical level. The Ocean Medicines programme also considers commercialization, innovation and entrepreneurship activities including how to start a new business and how to favour an industrial career to seconded researchers. We are confident that the establishment of this international research network, with its synergistic effects, will significantly contribute to advance all of the involved labs to the top level in the field of marine drug discovery.
|Final Workshop||Other||2020-02-12 15:37:37|
|Dissemination||Websites, patent fillings, videos etc.||2020-02-12 15:37:32|
|Business model development best practices for new companies||Documents, reports||2020-02-12 08:58:29|
|Case studies failed ventures||Documents, reports||2020-02-12 08:58:28|
|Case studies successful ventures||Documents, reports||2020-02-12 08:58:28|
|website||Websites, patent fillings, videos etc.||2020-02-12 08:58:28|
|Project meetings||Other||2020-02-12 08:58:28|
Take a look to the deliverables list in detail: detailed list of Ocean Medicines deliverables.
|year||authors and title||journal||last update|
Luca Rinaldi, Veronica Folliero, Luciana Palomba, Carla Zannella, Rachele Isticato, Raffaele Di Francia, Massimiliano Berretta, Ilario de Sio, Luigi E. Adinolfi, Giancarlo Morelli, Secondo Lastoria, Lucia Altucci, Carlo Pedone, Massimiliano Galdiero, Gianluigi Franci
Sonoporation by microbubbles as gene therapy approach against liver cancer
published pages: , ISSN: 1949-2553, DOI: 10.18632/oncotarget.25875
Federica Sarno, Chiara Papulino, Gianluigi Franci, Jeanette H. Andersen, Bastien Cautain, Colombina Melardo, Lucia Altucci, Angela Nebbioso
3-Chloro-Nâ€²-(2-hydroxybenzylidene) benzohydrazide: An LSD1-Selective Inhibitor and Iron-Chelating Agent for Anticancer Therapy
published pages: , ISSN: 1663-9812, DOI: 10.3389/fphar.2018.01006
|Frontiers in Pharmacology 9||2020-02-12|
Mariarosaria Conte, Raffaele De Palma, Lucia Altucci
HDAC inhibitors as epigenetic regulators for cancer immunotherapy
published pages: 65-74, ISSN: 1357-2725, DOI: 10.1016/j.biocel.2018.03.004
|The International Journal of Biochemistry & Cell Biology 98||2020-02-12|
Emiliana Tortorella, Pietro Tedesco, Fortunato Palma Esposito, Grant January, Renato Fani, Marcel Jaspars, Donatella de Pascale
Antibiotics from Deep-Sea Microorganisms: Current Discoveries and Perspectives
published pages: 355, ISSN: 1660-3397, DOI: 10.3390/md16100355
|Marine Drugs 16/10||2020-02-12|
Marco Miceli, Adele Cutignano, Mariarosaria Conte, Raffaella Ummarino, Alessandra Romanelli, Menotti Ruvo, Marilisa Leone, Flavia Anna Mercurio, Nunzianna Doti, Emiliano Manzo, Giovanna Romano, Lucia Altucci, Adrianna Ianora
Monoacylglycerides from the Diatom Skeletonema marinoi Induce Selective Cell Death in Cancer Cells
published pages: 625, ISSN: 1660-3397, DOI: 10.3390/md17110625
|Marine Drugs 17/11||2020-02-12|
Valeria Di Dato, Federica Di Costanzo, Roberta Barbarinaldi, Anna Perna, Adrianna Ianora, Giovanna Romano
Unveiling the presence of biosynthetic pathways for bioactive compounds in the Thalassiosira rotula transcriptome
published pages: , ISSN: 2045-2322, DOI: 10.1038/s41598-019-46276-8
|Scientific Reports 9/1||2020-02-12|
Fortunato Palma Esposito, Colin J. Ingham, Raquel Hurtado-Ortiz, Chantal Bizet, Deniz Tasdemir, Donatella de Pascale
Isolation by Miniaturized Culture Chip of an Antarctic bacterium Aequorivita sp. with antimicrobial and anthelmintic activity
published pages: e00281, ISSN: 2215-017X, DOI: 10.1016/j.btre.2018.e00281
|Biotechnology Reports 20||2020-02-12|
Paulina Corral, Fortunato Palma Esposito, Pietro Tedesco, Angela Falco, Emiliana Tortorella, Luciana Tartaglione, Carmen Festa, Maria Valeria Dâ€™Auria, Giorgio Gnavi, Giovanna Cristina Varese, Donatella de Pascale
Identification of a Sorbicillinoid-Producing Aspergillus Strain with Antimicrobial Activity Against Staphylococcus aureus: a New Polyextremophilic Marine Fungus from Barents Sea
published pages: , ISSN: 1436-2228, DOI: 10.1007/s10126-018-9821-9
Are you the coordinator (or a participant) of this project? Plaese send me more information about the "OCEAN MEDICINES" project.
For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.
Send me an email (email@example.com) and I put them in your project's page as son as possible.
Thanks. And then put a link of this page into your project's website.
The information about "OCEAN MEDICINES" are provided by the European Opendata Portal: CORDIS opendata.